Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research
Titel:
Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research
Auteur:
Polhemus, Mark E. Magill, Alan J. Cummings, James F. Kester, Kent E. Ockenhouse, Chris F. Lanar, David E. Dutta, Sheetij Barbosa, Arnoldo Soisson, Lorraine Diggs, Carter L. Robinson, Sally A. Haynes, John D. Stewart, V. Ann Ware, Lisa A. Brando, Clara Krzych, Urszula Bowden, Robert A. Cohen, Joe D. Dubois, Marie-Claude Ofori-Anyinam, Opokua De-Kock, Els Ballou, W. Ripley Heppner Jr., D. Gray